Multiple Sclerosis, Secondary Progressive

Neurology

Prevalence

120.0 / 100K

Incidence

7.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Multiple Sclerosis, Secondary Progressive?

There are 2 clinical trials targeting Multiple Sclerosis, Secondary Progressive tracked by BioSniper.

What is the prevalence of Multiple Sclerosis, Secondary Progressive?

The estimated prevalence of Multiple Sclerosis, Secondary Progressive is approximately 120.0 per 100,000 population.

Deep-dive into Multiple Sclerosis, Secondary Progressive

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Multiple Sclerosis, Secondary Progressive — Drugs in Development & Clinical Trials | BioSniper